Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 4 | 2019 | 1211 | 1.120 |
Why?
|
| Prediabetic State | 3 | 2018 | 76 | 1.060 |
Why?
|
| Hemangiosarcoma | 2 | 2018 | 11 | 1.060 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2018 | 99 | 1.010 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 466 | 0.880 |
Why?
|
| Heart Neoplasms | 2 | 2018 | 19 | 0.650 |
Why?
|
| Heart Failure | 4 | 2020 | 728 | 0.640 |
Why?
|
| Electrocardiography | 3 | 2019 | 624 | 0.580 |
Why?
|
| Pulmonary Valve | 1 | 2018 | 12 | 0.550 |
Why?
|
| Aneurysm | 1 | 2018 | 20 | 0.550 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 28 | 0.550 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 26 | 0.550 |
Why?
|
| Teaching | 1 | 2018 | 60 | 0.530 |
Why?
|
| Myocardial Contraction | 2 | 2015 | 59 | 0.510 |
Why?
|
| Blood Glucose | 2 | 2018 | 484 | 0.500 |
Why?
|
| Contrast Media | 2 | 2015 | 136 | 0.450 |
Why?
|
| Gadolinium | 1 | 2015 | 18 | 0.440 |
Why?
|
| Clinical Competence | 1 | 2018 | 329 | 0.440 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 19 | 0.430 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2013 | 5 | 0.410 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 17 | 0.410 |
Why?
|
| Atherosclerosis | 2 | 2020 | 821 | 0.400 |
Why?
|
| Ethnic Groups | 1 | 2015 | 450 | 0.380 |
Why?
|
| Heart Ventricles | 1 | 2013 | 146 | 0.380 |
Why?
|
| Stroke Volume | 4 | 2020 | 417 | 0.350 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 427 | 0.340 |
Why?
|
| Humans | 18 | 2020 | 32262 | 0.330 |
Why?
|
| Aged | 11 | 2020 | 10249 | 0.310 |
Why?
|
| Male | 12 | 2020 | 19429 | 0.250 |
Why?
|
| Female | 12 | 2020 | 19935 | 0.250 |
Why?
|
| Systole | 2 | 2019 | 94 | 0.240 |
Why?
|
| Heart | 2 | 2018 | 177 | 0.240 |
Why?
|
| Risk Factors | 7 | 2020 | 3933 | 0.240 |
Why?
|
| Coronary Circulation | 2 | 2015 | 41 | 0.220 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 2238 | 0.210 |
Why?
|
| Middle Aged | 10 | 2020 | 11837 | 0.210 |
Why?
|
| Ventricular Function, Left | 2 | 2015 | 264 | 0.190 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 3893 | 0.180 |
Why?
|
| Kidney | 2 | 2019 | 521 | 0.180 |
Why?
|
| Risk Assessment | 3 | 2020 | 1423 | 0.150 |
Why?
|
| Language | 1 | 2019 | 35 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 100 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 84 | 0.140 |
Why?
|
| Brain Mapping | 1 | 2019 | 190 | 0.140 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 126 | 0.140 |
Why?
|
| Fasting | 1 | 2018 | 88 | 0.140 |
Why?
|
| Hypertension | 2 | 2019 | 980 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2015 | 3609 | 0.140 |
Why?
|
| Nerve Net | 1 | 2019 | 137 | 0.140 |
Why?
|
| Phenotype | 1 | 2019 | 622 | 0.130 |
Why?
|
| Feedback | 1 | 2018 | 41 | 0.130 |
Why?
|
| Antihypertensive Agents | 2 | 2019 | 363 | 0.130 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 93 | 0.130 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 880 | 0.130 |
Why?
|
| Hospitalization | 1 | 2020 | 475 | 0.130 |
Why?
|
| Education, Medical | 1 | 2018 | 69 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2017 | 85 | 0.130 |
Why?
|
| Cardiology | 1 | 2018 | 104 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 60 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 77 | 0.120 |
Why?
|
| Students, Medical | 1 | 2018 | 126 | 0.120 |
Why?
|
| Prevalence | 2 | 2015 | 955 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1478 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 41 | 0.110 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 24 | 0.110 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 23 | 0.110 |
Why?
|
| Dobutamine | 1 | 2015 | 54 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2015 | 66 | 0.110 |
Why?
|
| Prognosis | 2 | 2020 | 1529 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 98 | 0.100 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2014 | 4 | 0.100 |
Why?
|
| Exercise Test | 1 | 2015 | 218 | 0.100 |
Why?
|
| African Americans | 1 | 2020 | 1335 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 42 | 0.100 |
Why?
|
| Myocardium | 1 | 2013 | 184 | 0.090 |
Why?
|
| Brain | 1 | 2019 | 966 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1111 | 0.090 |
Why?
|
| Abdominal Fat | 1 | 2010 | 39 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2010 | 320 | 0.070 |
Why?
|
| United States | 1 | 2015 | 4068 | 0.060 |
Why?
|
| Adult | 4 | 2020 | 9252 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 2315 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 1178 | 0.040 |
Why?
|
| Mississippi | 1 | 2020 | 38 | 0.040 |
Why?
|
| Individuality | 1 | 2019 | 10 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 236 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 286 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 759 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1241 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 544 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 395 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 63 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 141 | 0.030 |
Why?
|
| Acute Chest Syndrome | 1 | 2014 | 1 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2014 | 6 | 0.030 |
Why?
|
| Hemolysis | 1 | 2014 | 11 | 0.030 |
Why?
|
| Iron Overload | 1 | 2014 | 24 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 471 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2014 | 33 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 656 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 756 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 854 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 591 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 393 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1300 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 426 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 327 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2430 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 2643 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3509 | 0.010 |
Why?
|